First Tracks Biotherapeutics Inc(TRAX)

Biotechnology · San Diego, CA

$31.39-1.60 (-4.85%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T20:53:24.390Z.

Stored calculation inputs

Calculation as of: 2026-10-06T20:53:24.390Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 31.39
Unrounded diluted TTM EPS · period ending 2026-06-30: N/A

FMP input reference: efd168c3f67c3bcd8ce1d079285ce9769a1647edc12b2aee6a2fbd6fb78d637d

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

TRAX PE Ratio Metrics

PE RATIO

N/A

TRAX Competitors' PE Ratio

TRAX

First Tracks Biotherapeutics Inc

Current

Market Cap

$1.10B

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OPK

OPKO Health, Inc.

vs TRAX

Market Cap

$1.09B

PE Ratio

N/A

TTM Avg

38.94

3Y Avg

40.17

5Y Avg

40.17

BCAX

Bicara Therapeutics Inc. Common Stock

vs TRAX

Market Cap

$1.09B

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

STAA

STAAR Surgical Company

vs TRAX

Market Cap

$1.10B

PE Ratio

276.87

TTM Avg

283.35

3Y Avg

108.94

5Y Avg

117.69

IRMD

IRadimed Corporation

vs TRAX

Market Cap

$1.08B

PE Ratio

47.39

TTM Avg

53.07

3Y Avg

41.22

5Y Avg

45.14

TNDM

Tandem Diabetes Care, Inc.

vs TRAX

Market Cap

$1.11B

PE Ratio

N/A

TTM Avg

1054.26

3Y Avg

1054.26

5Y Avg

1054.26

REPL

Replimune Group, Inc.

vs TRAX

Market Cap

$1.11B

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AVLN

Avalyn Pharma Inc. Common Stock

vs TRAX

Market Cap

$1.13B

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HROW

Harrow Health, Inc.

vs TRAX

Market Cap

$1.13B

PE Ratio

N/A

TTM Avg

47.35

3Y Avg

23.64

5Y Avg

23.64

GDRX

GoodRx Holdings, Inc.

vs TRAX

Market Cap

$1.13B

PE Ratio

76.94

TTM Avg

42.78

3Y Avg

72.87

5Y Avg

84.11

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
First Tracks Biotherapeutics Inc (TRAX)	$1.10B	N/A	N/A	N/A	N/A
OPKO Health, Inc. (OPK)vs ›	$1.09B	N/A	38.94	40.17	40.17
Bicara Therapeutics Inc. Common Stock (BCAX)vs ›	$1.09B	N/A	N/A	N/A	N/A
STAAR Surgical Company (STAA)vs ›	$1.10B	276.87	283.35	108.94	117.69
IRadimed Corporation (IRMD)vs ›	$1.08B	47.39	53.07	41.22	45.14
Tandem Diabetes Care, Inc. (TNDM)vs ›	$1.11B	N/A	1054.26	1054.26	1054.26
Replimune Group, Inc. (REPL)vs ›	$1.11B	N/A	N/A	N/A	N/A
Avalyn Pharma Inc. Common Stock (AVLN)vs ›	$1.13B	N/A	N/A	N/A	N/A
Harrow Health, Inc. (HROW)vs ›	$1.13B	N/A	47.35	23.64	23.64
GoodRx Holdings, Inc. (GDRX)vs ›	$1.13B	76.94	42.78	72.87	84.11

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$31.39

Forward EPS (Est.)

$-4.12

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

TRAX PE Ratio Metrics

TRAX Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics